Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L T Meltzer

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Pharmaceutical Research|March 1, 1997
Pharmacokinetics and pharmacodynamics of an investigational antipsychotic agent, CI-1007, in rats and monkeysM R Feng, A E Corbin, Y Wang, et al.
Journal of Medicinal Chemistry|September 9, 2000
Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(heteroarylalkynyl)-4-benzylpiperidinesJ L Wright, T F Gregory, S R Kesten, et al.
Journal of Medicinal Chemistry|September 23, 2000
Thiazoloindans and thiazolobenzopyrans: a novel class of orally active central dopamine (partial) agonistsL A van Vliet, N Rodenhuis, H Wikström, et al.
Journal of Medicinal Chemistry|August 24, 2000
Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907)L A van Vliet, N Rodenhuis, D Dijkstra, et al.
Journal of Medicinal Chemistry|July 8, 1999
Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(arylalkynyl)-4-benzylpiperidinesJ L Wright, T F Gregory, C F Bigge, et al.
Neuropharmacology|April 13, 2000
PD 158771, a potential antipsychotic agent with D(2)/D(3) partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effectsH C Akunne, K T Zoski, M D Davis, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Pharmaceutical Research|March 1, 1997
Pharmacokinetics and pharmacodynamics of an investigational antipsychotic agent, CI-1007, in rats and monkeysM R Feng, A E Corbin, Y Wang, et al.
Journal of Medicinal Chemistry|September 9, 2000
Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(heteroarylalkynyl)-4-benzylpiperidinesJ L Wright, T F Gregory, S R Kesten, et al.
Journal of Medicinal Chemistry|September 23, 2000
Thiazoloindans and thiazolobenzopyrans: a novel class of orally active central dopamine (partial) agonistsL A van Vliet, N Rodenhuis, H Wikström, et al.
Journal of Medicinal Chemistry|August 24, 2000
Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907)L A van Vliet, N Rodenhuis, D Dijkstra, et al.
Journal of Medicinal Chemistry|July 8, 1999
Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(arylalkynyl)-4-benzylpiperidinesJ L Wright, T F Gregory, C F Bigge, et al.
Neuropharmacology|April 13, 2000
PD 158771, a potential antipsychotic agent with D(2)/D(3) partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effectsH C Akunne, K T Zoski, M D Davis, et al.
Pageof 5